[Objective] To explore the effects of Fufang Xueshuantong capsule(FXST) on the kidney function in diabetic nephropathy(DN) rats and to investigate its possible mechanism. [Methods] SD rats were fed with high fat diet and injected with STZ to make diabetic nephropathy(DN) model. DN rats were randomly divided into four groups: low dose(XSTL), medium dose(XSTM), high dose(XSTH)FXST groups(treated with 0.3, 0.6, 1.2 g/kg/d FXST, respectively, n=10), and DN model group(treated with saline, n=10). Normal rats were enrolled as normal group(treated with saline, n=10). The fasting blood glucose, weight, 24-h urinary albumin, urinary creatinine,blood creatinine and blood urea nitrogen were tested. Illumina Rat Ref-12 Expression Bead Chip gene array experiment was done using kidney of rats. [Results] FXST could reduce 24-h urinary albumin, serum creatinine and serum urea nitrogen, and increase urinary creatinine in a dose dependent manner compared with those of DN model group(P0.05 or P0.01). Gene array showed that FXST significantly changed expression of genes(34 increased, 33 decreased). Real-time PCR showed that relative levels for Col1a1, Ctgf and Tgfb1 were significantly decreased in FXST group, compared with the model group. Cyp2c23 and Nphs1 were increased. [Conclusion] FXST can moderate the kidney function in DN rats. The mechanism may be involved with BMP2-TGFβ-CTGF pathway, CYP2C23 and podocytes proteins.